Table 2.
Study patient characteristics
| Characteristics | Low activity | Moderate activity | High activity | Total |
| (N=13 366) | (N=22 526) | (N=29 469) | (N=65 361) | |
| Age band—no (%) | ||||
| 18–34 | 3822 (28.6) | 7149 (31.7) | 8823 (29.9) | 19 794 (30.3) |
| 35–49 | 5975 (44.7) | 9273 (41.2) | 13 341 (45.3) | 28 589 (43.7) |
| 50–59 | 2517 (18.8) | 4013 (17.8) | 5114 (17.4) | 11 644 (17.8) |
| 60+ | 1052 (7.9) | 2091 (9.3) | 2191 (7.4) | 5334 (8.2) |
| Sex—no (%) | ||||
| Female | 7658 (57.3) | 11 276 (50.1) | 12 564 (42.6) | 31 498 (48.2) |
| Male | 5708 (42.7) | 11 250 (49.9) | 16 905 (57.4) | 33 863 (51.8) |
| RUB—no (%) | ||||
| 0—Non-users | 835 (6.2) | 1549 (6.9) | 2322 (7.9) | 4706 (7.2) |
| 1—Healthy users | 1169 (8.7) | 2134 (9.5) | 3215 (10.9) | 6518 (10) |
| 2—Low morbidity | 2161 (16.2) | 3811 (16.9) | 5104 (17.3) | 11 076 (16.9) |
| 3—Moderate | 7176 (53.7) | 12 010 (53.3) | 15 651 (53.1) | 34 837 (53.3) |
| 4—High | 1492 (11.2) | 2280 (10.1) | 2534 (8.6) | 6306 (9.6) |
| 5—Very high | 533 (4) | 742 (3.3) | 643 (2.2) | 1918 (2.9) |
| Chronic conditions—no (%) | ||||
| Oncology | 308 (2.30) | 533 (2.37) | 616 (2.09) | 1457 (2.23) |
| Essential hypertension | 2115 (15.82) | 3254 (14.45) | 3284 (11.14) | 8653 (13.24) |
| Hypercholesterolaemia | 1440 (10.77) | 2322 (10.31) | 2426 (8.23) | 6188 (9.47) |
| Asthma | 809 (6.05) | 1299 (5.77) | 1827 (6.2) | 3935 (6.02) |
| Diabetes mellitus | 918 (6.87) | 1183 (5.25) | 931 (3.16) | 3032 (4.64) |
| Hypothyroidism | 432 (3.23) | 636 (2.82) | 746 (2.53) | 1814 (2.78) |
| HIV infection | 274 (2.05) | 427 (1.90) | 297 (1.01) | 998 (1.53) |
| Epilepsy | 165 (1.23) | 235 (1.04) | 291 (0.99) | 691 (1.06) |
| Rheumatoid arthritis | 151 (1.13) | 211 (0.94) | 211 (0.72) | 573 (0.88) |
| Conduction disorder | 104 (0.78) | 199 (0.88) | 207 (0.70) | 510 (0.78) |
| Congestive cardiac failure | 78 (0.58) | 100 (0.44) | 68 (0.23) | 246 (0.38) |
| Ulcerative colitis | 50 (0.37) | 81 (0.36) | 91 (0.31) | 222 (0.34) |
| Systemic lupus erythematosus | 57 (0.43) | 55 (0.24) | 53 (0.18) | 165 (0.25) |
| Chronic renal failure | 43 (0.32) | 57 (0.25) | 50 (0.17) | 150 (0.23) |
| Crohn’s disease | 25 (0.19) | 40 (0.18) | 55 (0.19) | 120 (0.18) |
| Cardiomyopathy | 25 (0.19) | 41 (0.18) | 39 (0.13) | 105 (0.16) |
| Multiple sclerosis | 15 (0.11) | 31 (0.14) | 34 (0.12) | 80 (0.12) |
| Bronchiectasis | 4 (0.03) | 10 (0.04) | 16 (0.05) | 30 (0.05) |
| Angina syndrome | 4 (0.03) | 5 (0.02) | 13 (0.04) | 22 (0.03) |
RUB, resource utilisation bands.